BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of over 1000 found
  Current Search:  agreement: 5919     

HTML
100%
NicOx reports first quarter 2008 financial results
SOPHIA ANTIPOLIS, FRANCE -- (MARKET WIRE) -- 05/14/08 -- May 14, 2008.

Sophia Antipolis, France.

www.nicox.com NicOx S.A.

(Eurolist: COX) today reported financial results for the first three months of 2008.

On March 31, 2008, the...

Houston Chronicle:  May 14 2008 10:14AM
Matching: agreement
Find similar documents
HTML
100%
NicOx reports first quarter 2008 financial results
NicOx S.A.

(Eurolist: COX) today reported financial results for the first three months of 2008.

On March 31, 2008, the Company had cash, cash equivalents and financial instruments of EUR 153.7 million, compared to EUR 201.2 million on...

TMC Net:  May 14 2008 5:39AM
Matching: agreement
Find similar documents
HTML
100%
NicOx reports first quarter 2008 financial results
Sophia Antipolis, France.

www.nicox.com NicOx S.A.

(Eurolist: COX) today reported financial results for the first three months of 2008.

On March 31, 2008, the Company had cash, cash equivalents and financial instruments of EUR 153.7...

Calibre Macro World:  May 14 2008 5:11AM
Matching: agreement
Find similar documents
HTML
100%
NicOx Reports First Quarter 2008 Financial Results
SOPHIA ANTIPOLIS, France, May 14 /PRNewswire-FirstCall/ -- NicOx S.A.

(News) (Eurolist: COX) today reported financial results for the first three months of 2008.

On March 31, 2008, the Company had cash, cash equivalents and financial...

FinanzNachrichten.de:  May 14 2008 11:35AM
Matching: agreement
Find similar documents
HTML
100%
Viterra and BioExx Execute Long-Term Supply Agreement
, 4:04 AM EST Viterra Inc.

(TSX: VT) ('Viterra') and Bio-Extraction Inc.

(TSX VENTURE: BXI) ('BioExx') are pleased to announce that they have entered into a long-term Canola Supply Agreement under which Viterra will supply canola...

Genetic Engineering News:  May 14 2008 11:30AM
Matching: agreement
Find similar documents
HTML
100%
Adherex Announces Agreement for STS Phase III Data
ET RESEARCH TRIANGLE PARK, NORTH CAROLINA--(MARKET WIRE)--May 14, 2008 -- Adherex Technologies Inc.

(Toronto: - )(AMEX: - ), a biopharmaceutical company devoted to solving problems for patients with cancer, announced today a license ...

Yahoo!:  May 14 2008 3:40PM
Matching: agreement
Find similar documents
HTML
100%
ADH: License Agreement w/Netherlands Cancer Institute for Use of Ph III Data
ADHEREX TECHNOLOGIES INC By Fain Hughes, fhughes@knobias.com Adherex Technologies Inc.

(ADH) announced a license agreement with the Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital (NKI-AVL), for the exclusive use of...

Therapeutics Daily:  May 14 2008 3:01PM
Matching: agreement
Find similar documents
HTML
100%
Forest and Daiichi Sankyo end hypertensive pact
Forest Laboratories, Inc.

a U.S.-based pharmaceutical company, and Daiichi Sankyo, Inc.

have terminated their co-promotion agreement for Azor (amlodipine and olmesartan medoxomil), Daiichi Sankyo's fixed-dose combination of two...

PharmaBiz:  May 14 2008 6:56AM
Matching: agreement
Find similar documents
HTML
100%
Intas Biopharma to expand operations in Middle East, North Africa
The Ahmedabad based, Intas Biopharmaceuticals Ltd is expanding its operations in Middle East and North Africa (MENA).

The company is looking forward to supply and market three products, Neukine, Erykine and Intalfa in these markets.

The...

PharmaBiz:  May 14 2008 3:52AM
Matching: agreement
Find similar documents
HTML
100%
Settling it out
Of late, pharmaceutical companies seem to be resorting to out-of-court settlements, in a bid to put an end to time consuming legal hassles and piling up bills.

Suja Nair analyses recent out-of-court settlements There is fierce competition...

Express Pharma:  May 14 2008 12:45AM
Matching: agreement
Find similar documents
HTML
100%
Warnex Reports First Quarter 2008 Results
- First quarter revenue of $6.1 million and net loss of $0.3 million - Signed agreements in principle with Warnex's various debenture holders in order to modify the terms and conditions of the long term debentures - Signed 10-year...
NewsBlaze:  May 13 2008 11:13PM
Matching: agreement
Find similar documents
HTML
100%
Co-Development and Co-Marketing Agreement Secured for the Activated Vitamin D Derivative, ED-71
(Tokyo) - Chugai Pharmaceutical Co., Ltd.

('Chugai') [Head Office: Chuo-ku, Tokyo; President: Osamu Nagayama] announced today that it has entered into an agreement with Taisho Pharmaceutical Co., Ltd.

('Taisho') [Head Office:...

CHUGAI PHARMACEUTICAL:  May 14 2008 4:34PM
Matching: agreement
Find similar documents
HTML
100%
Adherex Announces Agreement for STS Phase III Data
- Adherex Technologies Inc.

(TSX:AHX)(AMEX:ADH), a biopharmaceutical company devoted to solving problems for patients with cancer, announced today a license agreement with the Netherlands Cancer Institute - Antoni van Leeuwenhoek...

Therapeutics Daily:  May 14 2008 1:13PM
Matching: agreement
Find similar documents
HTML
100%
GSK signs pact with Japanese firm
Mumbai (PTI): Pharmaceutical firm GlaxoSmithKline (GSK) Pharma on Wednesday said it has entered into an agreement with Daiichi Sankyo India Pharma Limited (DSIPL) for jointly promoting the anti-hypertensive drug Olmesartan Medoxomil...
The Hindu:  May 14 2008 7:10AM
Matching: agreement
Find similar documents
HTML
100%
Forest and Daiichi terminate Azor co-promotion agreement
Forest will record a one-time charge of $44.1 million which is composed of a one-time payment to Daiichi Sankyo of $26.6 million related to the termination and $17.5 million related to the unamortized portion of the initial upfront payment....
Pharmaceutical Business Review:  May 14 2008 4:08AM
Matching: agreement
Find similar documents
HTML
100%
Indevus Pharmaceuticals Inc. F2Q08 (Qtr End 3/31/08) Earnings Call Transcript
Good day ladies and gentlemen and welcome to the 2008 second quarter Indevus Pharmaceuticals Incorporated Earnings Call.

My name is Cynthia, and Ill be your Operator for todays call.

At this time, all participants are in a listen-only...

Yahoo!:  May 14 2008 3:13AM
Matching: agreement
Find similar documents
HTML
100%
Crucell Announces First Quarter 2008 Results
Total revenue and other operating income of EUR 47.9 million, showing 36% growth in the first quarter of 2008 compared to EUR 35.2 million in the same period of 2007.

Net loss in the quarter halved to EUR 9.0 million compared to Q107.

Yahoo!:  May 13 2008 6:24AM
Matching: agreement
Find similar documents
HTML
100%
Full Article
Avoid Misunderstanding by Making Sure Your Agreement Is Clear and Accurate Larry A.

Roberts So, youve got a patent but you dont have the resources to market the patented invention.

Or you have the manufacturing and marketing...

Genetic Engineering News:  May 13 2008 9:39PM
Matching: agreement
Find similar documents
HTML
100%
Ranbaxy & Merck Sign Strategic Product Development Agreement in anti-infective field
Ranbaxy Laboratories Ltd has announced today that they have signed a strategic Product Development Agreement (the 'Agreement') providing for a drug discovery and clinical development collaboration for new products, in the anti...
Equity Bulls:  May 13 2008 10:54AM
Matching: agreement
Find similar documents
HTML
100%
EP MedSystems Reports 2008 First Quarter Results
, 4:37 PM EST News source: Business Wire EP MedSystems, Inc.

(NASDAQ: EPMD), today reported its financial results for the first quarter ending March 31, 2008.

The Company achieved quarterly revenue of $4.6 million, representing a 29%...

Genetic Engineering News:  May 13 2008 9:27PM
Matching: agreement
Find similar documents
HTML
100%
Quest PharmaTech Signs Agreement to sell Bionex Technology
uest PharmaTech Inc.

announced that it has signed a Technology Transfer Agreement with Peking Marvel Cleansing Supplies Co., Ltd., a China-based company, to sell its interest in the Bionex Technology.

Peking Marvel is anticipated...

Bionity.com:  May 13 2008 3:28AM
Matching: agreement
Find similar documents
HTML
100%
Forest Laboratories and Daiichi Sankyo Terminate AZOR Copromotion Agreement
Forest Laboratoriesand Daiichi Sankyo terminated their copromotion agreement for AZOR (amlodipine and olmesartan medoxomil), Daiichi Sankyo's fixed-dose combination of two antihypertensives, the calcium channel blocker amlodipine...
Genetic Engineering News:  May 13 2008 9:56AM
Matching: agreement
Find similar documents
HTML
100%
Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
NEW YORK and PARSIPPANY, N.J., May 12 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc.

, a U.S.-based pharmaceutical company, and Daiichi Sankyo, Inc.

today announced that they have terminated their co-promotion agreement for...

SmartBrief:  May 12 2008 11:27PM
Matching: agreement
Find similar documents
HTML
100%
Skinvisible Signs Licensing Agreement For Two Acne Formulations
New Retinoic Acid and Clindamycin Products Developed with Invisicare LAS VEGAS, Nevada - May 13, 2008 - Skinvisible, Inc.

(OTC Bulletin Board: SKVI / http://www.skinvisible.com), a research and development company focused on formulating...

Pharma Live:  May 13 2008 8:11PM
Matching: agreement
Find similar documents
HTML
100%
Examine The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profi
The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles http://www.reportlinker.com/p088534/The-Fastest-Growing-Biotechnology-Companies- Growth-strategies-comparative-analyses-and-company...
TMC Net:  May 13 2008 2:00AM
Matching: agreement
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.